Symbollon warns of trouble after Phase III failure
This is a discussion on Symbollon warns of trouble after Phase III failure within the Biotechnology News forum, part of the Industry News and Updates category; Symbollon Pharmaceuticals says its pain therapy IoGen flunked a late stage trial for moderate to severe cyclic pain associated with ...
|
|||||||
| Register | Help | Members List | Mark Forums Read |
04-10-2008, 02:36 PM
|
|||
|
|||
Symbollon warns of trouble after Phase III failure
Symbollon Pharmaceuticals says its pain therapy IoGen flunked a late stage trial for moderate to severe cyclic pain associated with fibrocystic breast disease. And the results could well threaten the Read more...
More... 
|
Linear Mode
